Human PRPS1 and PRPS2 have been identified in acute lymphoblastic leukaemia (ALL) as the major cause of drug resistance to the prodrugs thioguanine and thiopurine, which are used in cancer therapy [189,190,191,192]. The gene discussed is PRPS2; the disease is acute lymphoblastic leukemia.